Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 795

1.

Identification of novel synaptonemal complex components in C. elegans.

Hurlock ME, Čavka I, Kursel LE, Haversat J, Wooten M, Nizami Z, Turniansky R, Hoess P, Ries J, Gall JG, Rog O, Köhler S, Kim Y.

J Cell Biol. 2020 May 4;219(5). pii: e201910043. doi: 10.1083/jcb.201910043.

PMID:
32211899
2.

ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms.

Viaud M, Abdel-Wahab O, Gall J, Ivanov S, Guinamard R, Sore S, Merlin J, Ayrault M, Guilbaud E, Jacquel A, Auberger P, Wang N, Levine RL, Tall AR, Yvan-Charvet L.

Cell Rep. 2020 Mar 10;30(10):3397-3410.e5. doi: 10.1016/j.celrep.2020.02.056.

3.

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen.

Ou L, Kong WP, Chuang GY, Ghosh M, Gulla K, O'Dell S, Varriale J, Barefoot N, Changela A, Chao CW, Cheng C, Druz A, Kong R, McKee K, Rawi R, Sarfo EK, Schön A, Shaddeau A, Tsybovsky Y, Verardi R, Wang S, Wanninger TG, Xu K, Yang GJ, Zhang B, Zhang Y, Zhou T; VRC Production Program, Arnold FJ, Doria-Rose NA, Lei QP, Ryan ET, Vann WF, Mascola JR, Kwong PD.

Sci Rep. 2020 Feb 20;10(1):3032. doi: 10.1038/s41598-020-59711-y.

4.

Superresolution imaging of chromatin fibers to visualize epigenetic information on replicative DNA.

Wooten M, Li Y, Snedeker J, Nizami ZF, Gall JG, Chen X.

Nat Protoc. 2020 Mar;15(3):1188-1208. doi: 10.1038/s41596-019-0283-y. Epub 2020 Feb 12.

PMID:
32051613
5.

Effect of inducible bone morphogenetic protein 2 expression on the osteogenic differentiation of dental pulp stem cells in vitro.

Tóth F, Gáll JM, Tőzsér J, Hegedűs C.

Bone. 2020 Mar;132:115214. doi: 10.1016/j.bone.2019.115214. Epub 2019 Dec 26.

6.

The human nucleolus organizer regions.

Gall JG.

Genes Dev. 2019 Dec 1;33(23-24):1617-1618. doi: 10.1101/gad.334748.119. Review.

PMID:
31792016
7.

"Lost and Found": snoRNA Annotation in the Xenopus Genome and Implications for Evolutionary Studies.

Deryusheva S, Talhouarne GJS, Gall JG.

Mol Biol Evol. 2020 Jan 1;37(1):149-166. doi: 10.1093/molbev/msz209.

8.

Small, Smaller, Smallest: Minimal Structural Requirements for a Fully Functional Box C/D Modification Guide RNA.

Deryusheva S, Gall JG.

Biomolecules. 2019 Sep 7;9(9). pii: E457. doi: 10.3390/biom9090457.

9.

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial.

Gaudinski MR, Houser KV, Doria-Rose NA, Chen GL, Rothwell RSS, Berkowitz N, Costner P, Holman LA, Gordon IJ, Hendel CS, Kaltovich F, Conan-Cibotti M, Gomez Lorenzo M, Carter C, Sitar S, Carlton K, Gall J, Laurencot C, Lin BC, Bailer RT, McDermott AB, Ko SY, Pegu A, Kwon YD, Kwong PD, Namboodiri AM, Pandey JP, Schwartz R, Arnold F, Hu Z, Zhang L, Huang Y, Koup RA, Capparelli EV, Graham BS, Mascola JR, Ledgerwood JE; VRC 605 study team.

Lancet HIV. 2019 Oct;6(10):e667-e679. doi: 10.1016/S2352-3018(19)30181-X. Epub 2019 Aug 28.

PMID:
31473167
10.

A proof of concept for structure-based vaccine design targeting RSV in humans.

Crank MC, Ruckwardt TJ, Chen M, Morabito KM, Phung E, Costner PJ, Holman LA, Hickman SP, Berkowitz NM, Gordon IJ, Yamshchikov GV, Gaudinski MR, Kumar A, Chang LA, Moin SM, Hill JP, DiPiazza AT, Schwartz RM, Kueltzo L, Cooper JW, Chen P, Stein JA, Carlton K, Gall JG, Nason MC, Kwong PD, Chen GL, Mascola JR, McLellan JS, Ledgerwood JE, Graham BS; VRC 317 Study Team.

Science. 2019 Aug 2;365(6452):505-509. doi: 10.1126/science.aav9033.

PMID:
31371616
11.

Asymmetric histone inheritance via strand-specific incorporation and biased replication fork movement.

Wooten M, Snedeker J, Nizami ZF, Yang X, Ranjan R, Urban E, Kim JM, Gall J, Xiao J, Chen X.

Nat Struct Mol Biol. 2019 Aug;26(8):732-743. doi: 10.1038/s41594-019-0269-z. Epub 2019 Jul 29.

12.

miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate.

Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall JB, Yang X, Hocker JD, Escobar TM, He S, Dell'Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L.

Nat Commun. 2019 May 14;10(1):2157. doi: 10.1038/s41467-019-09882-8.

13.

Patient and clinician engagement with health information in the primary care waiting room: A mixed methods case study.

Penry Williams C, Elliott K, Gall J, Woodward-Kron R.

J Public Health Res. 2019 Mar 11;8(1):1476. doi: 10.4081/jphr.2019.1476. eCollection 2019 Mar 11.

14.

Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.

Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoové MA, Wright EJ; PrEPX Study Team.

JAMA. 2019 Apr 9;321(14):1380-1390. doi: 10.1001/jama.2019.2947.

15.

How to modify persisting negative expectations in major depression? An experimental study comparing three strategies to inhibit cognitive immunization against novel positive experiences.

Kube T, Glombiewski JA, Gall J, Touissant L, Gärtner T, Rief W.

J Affect Disord. 2019 May 1;250:231-240. doi: 10.1016/j.jad.2019.03.027. Epub 2019 Mar 6.

PMID:
30870773
16.

Synthesis and crystal structure of 2,4,6,8-tetra-kis-(3,5-di-tert-butyl-phen-oxy)pyrimido[5,4-d]pyrimidine: expansion of the Piedfort concept.

Gall JH, MacNicol DD, MacSween R, Frampton CS.

Acta Crystallogr E Crystallogr Commun. 2019 Feb 22;75(Pt 3):383-387. doi: 10.1107/S2056989019002470. eCollection 2019 Mar 1.

17.

The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity.

Gautam S, Fioravanti J, Zhu W, Le Gall JB, Brohawn P, Lacey NE, Hu J, Hocker JD, Hawk NV, Kapoor V, Telford WG, Gurusamy D, Yu Z, Bhandoola A, Xue HH, Roychoudhuri R, Higgs BW, Restifo NP, Bender TP, Ji Y, Gattinoni L.

Nat Immunol. 2019 Mar;20(3):337-349. doi: 10.1038/s41590-018-0311-z. Epub 2019 Feb 18.

18.

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.

Gaudinski MR, Coates EE, Novik L, Widge A, Houser KV, Burch E, Holman LA, Gordon IJ, Chen GL, Carter C, Nason M, Sitar S, Yamshchikov G, Berkowitz N, Andrews C, Vazquez S, Laurencot C, Misasi J, Arnold F, Carlton K, Lawlor H, Gall J, Bailer RT, McDermott A, Capparelli E, Koup RA, Mascola JR, Graham BS, Sullivan NJ, Ledgerwood JE; VRC 608 Study team.

Lancet. 2019 Mar 2;393(10174):889-898. doi: 10.1016/S0140-6736(19)30036-4. Epub 2019 Jan 24.

19.

A Phase 1 Study of Intravenous Plazomicin in Healthy Adults to Assess Potential Effects on the QT/QTc Interval, Safety, and Pharmacokinetics.

Gall J, Choi T, Riddle V, Van Wart S, Gibbons JA, Seroogy J.

Clin Pharmacol Drug Dev. 2019 Nov;8(8):1032-1041. doi: 10.1002/cpdd.653. Epub 2019 Jan 16.

PMID:
30650259
20.

A Hybrid RNN-HMM Approach for Weakly Supervised Temporal Action Segmentation.

Kuehne H, Richard A, Gall J.

IEEE Trans Pattern Anal Mach Intell. 2020 Apr;42(4):765-779. doi: 10.1109/TPAMI.2018.2884469. Epub 2018 Dec 21.

PMID:
30582525

Supplemental Content

Loading ...
Support Center